BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17786972)

  • 1. Loss of Smad4 protein expression and 18qLOH as molecular markers indicating lymph node metastasis in colorectal cancer--a study matched for tumor depth and pathology.
    Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
    J Surg Oncol; 2008 Jan; 97(1):69-73. PubMed ID: 17786972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N- classification.
    Tanaka T; Watanabe T; Kazama Y; Tanaka J; Kanazawa T; Kazama S; Nagawa H
    Br J Cancer; 2006 Dec; 95(11):1562-7. PubMed ID: 17088901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 18q deletion as a novel molecular predictor for colorectal cancer with simultaneous hepatic metastasis.
    Tanaka T; Watanabe T; Kitayama J; Kanazawa T; Kazama Y; Tanaka J; Kazama S; Nagawa H
    Diagn Mol Pathol; 2009 Dec; 18(4):219-25. PubMed ID: 19861895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAD4 levels and response to 5-fluorouracil in colorectal cancer.
    Alhopuro P; Alazzouzi H; Sammalkorpi H; Dávalos V; Salovaara R; Hemminki A; Järvinen H; Mecklin JP; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Sep; 11(17):6311-6. PubMed ID: 16144935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis.
    Miyaki M; Iijima T; Konishi M; Sakai K; Ishii A; Yasuno M; Hishima T; Koike M; Shitara N; Iwama T; Utsunomiya J; Kuroki T; Mori T
    Oncogene; 1999 May; 18(20):3098-103. PubMed ID: 10340381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
    Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
    Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer.
    Ghadimi BM; Grade M; Liersch T; Langer C; Siemer A; Füzesi L; Becker H
    Clin Cancer Res; 2003 May; 9(5):1808-14. PubMed ID: 12738738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
    Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
    Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad4 may help to identify a subset of colorectal cancer patients with early recurrence after curative therapy.
    Ahn BK; Jang SH; Paik SS; Lee KH
    Hepatogastroenterology; 2011; 58(112):1933-6. PubMed ID: 22024061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
    Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
    Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Deletion mapping of chromosome 18q and Smad proteins expression analysis in urinary bladder carcinomas].
    Fan Z; Zhang J; Bai J
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):135-7. PubMed ID: 11783019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
    Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping of 18q in conventional renal cell carcinoma.
    Hirata H; Matsuyama H; Matsumoto H; Korenaga Y; Ohmi C; Sakano S; Yoshihiro S; Naito K
    Cancer Genet Cytogenet; 2005 Dec; 163(2):101-5. PubMed ID: 16337851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMAD4/DPC4 expression and prognosis in human colorectal cancer.
    Isaksson-Mettävainio M; Palmqvist R; Forssell J; Stenling R; Oberg A
    Anticancer Res; 2006; 26(1B):507-10. PubMed ID: 16739311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphatic infiltration identified by D2-40 monoclonal antibody predicts lymph node metastasis in submucosal invasive colorectal cancer.
    Kawaura K; Fujii S; Murata Y; Hasebe T; Ishii G; Itoh T; Sano Y; Saito N; Ochiai A
    Pathobiology; 2007; 74(6):328-35. PubMed ID: 18087197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between vascular endothelial growth factor C expression level and lymph node metastasis in non small cell lung cancer].
    Li J; Li BL; Zhang HQ; Xu SF; Liu ZD; Yue WT; Han Y
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2982-5. PubMed ID: 19080076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialoglycoconjugate expression in primary colorectal cancer and metastatic lymph node tissues.
    Inagaki Y; Tang W; Guo Q; Kokudo N; Sugawara Y; Karako H; Konishi T; Nakata M; Nagawa H; Makuuchi M
    Hepatogastroenterology; 2007; 54(73):53-7. PubMed ID: 17419230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
    Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.